Zobrazeno 1 - 10
of 104
pro vyhledávání: '"G. R. Blumenschein"'
Autor:
F. Graf Finckenstein, C. T. Harbison, Everett E. Vokes, Scott J. Antonia, Oscar Arrieta, Enriqueta Felip, Charles M. Rudin, Julie R. Brahmer, Naiyer A. Rizvi, J. Fayette, M. Steins, Neal Ready, L. Crina, Marco Angelo Burgio, C. Dorange, D. R. Spigel, Scott N. Gettinger, Leora Horn, Esther Holgado, F. Barlesi, David E. Gerber, Hossein Borghaei, Luis Paz-Ares, L.Q. Chow, M. Kohlhufl, H. Lena, G. R. Blumenschein, Elena Poddubskaya
Publikováno v:
The New England journal of medicine. 373(17)
Nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, disrupts PD-1-mediated signaling and may restore antitumor immunity.In this randomized, open-label, international phase 3 study, we assigned patients with n
Autor:
G R, Blumenschein, A, DiStefano, J, Caderao, B, Fristenberg, J, Adams, L H, Schweichler, L, Drinkard
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(12 Pt 2)
To determine the effectiveness of non-cross-resistant late-consolidation chemotherapy in locally advanced breast cancer (LABC) and stage IV breast cancer, we review our experience with two regimens. Between 1985 and 1991, we enrolled 56 patients with
Autor:
K A, Dicke, D L, Hood, M, Arneson, L, Fulbright, A, DiStefano, B, Firstenberg, J, Adams, G R, Blumenschein
Publikováno v:
Experimental hematology. 25(1)
The brief administration of G-CSF to previously treated solid tumor patients has a positive impact on the overall cellularity and progenitor cell content of harvested bone marrow. Fifty-seven patients, fully recovered from therapy and growth factor s
Autor:
A. L. Sabichi, M. S. Kies, B. S. Glisson, C. Lu, L. E. Ginsberg, C. I. Bartos, L. Feng, H. T. Tran, S. M. Lippman, G. R. Blumenschein
Publikováno v:
Journal of Clinical Oncology. 28:5532-5532
Autor:
A. B. Sandler, G. R. Blumenschein, T. Henderson, J. Lee, M. Truong, E. Kim, B. Mass, B. Garcia, D. H. Johnson, R. S. Herbst
Publikováno v:
Journal of Clinical Oncology. 22:2000-2000
Publikováno v:
Cancer treatment reports. 68(7-8)
Forty-two patients with metastatic breast carcinoma previously treated with a combination of cyclophosphamide, methotrexate, and 5-FU, with or without vincristine or prednisone, were treated at relapse with a sequential combination of doxorubicin and
Autor:
G N, Hortobagyi, J U, Gutterman, G R, Blumenschein, A, Buzdar, M A, Burgess, S P, Richman, C K, Tashima, M, Schwarz, E M, Hersh
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. (62)
Publikováno v:
Cancer treatment reports. 66(7)
9,10-Anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-y1)-hydrazone ]dihydrochloride (bisantrene) is one of a series of anthracenedicarboxyaldehyde compounds that has significant antitumor activity similar to that of doxorubicin in experimen
Autor:
M B, Ross, A U, Buzdar, T L, Smith, N, Eckles, G N, Hortobagyi, G R, Blumenschein, E J, Freireich, E A, Gehan
Publikováno v:
Cancer. 55(2)
Groups of patients with newly diagnosed metastatic breast cancer who were consecutively registered into a breast cancer clinic beginning January 1956 (210 patients), January 1966 (210 patients), and January 1975 (251 patients), were analyzed to deter
Publikováno v:
Cancer treatment reports. 63(11-12)
A phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) was carried out in previously treated patients with metastatic breast cancer. Four of 26 evaluable patients achieved partial responses and four showed minor responses. The maxi